On the recordSeptember 7, 2011
I think there are some legitimate concerns here about cost-benefit analysis and particularly when you have said yourself since you have been at EPA, the costs have never exceeded the benefits.
Source
congress.govI think there are some legitimate concerns here about cost-benefit analysis and particularly when you have said yourself since you have been at EPA, the costs have never exceeded the benefits.
Whitfield questions the validity of EPA's cost-benefit analysis regarding health regulations.
Share
More from Ed Whitfield
EPA is pushing a back door cap-and-trade policy without congressional approval.
In order to reach Congress' statutory volumes there needs to be more ethanol in the system than can be absorbed just through E10.